Epidemiology of oral human papillomavirus infection

Oral Oncology

Volumn 50, Issue 5, 2014, Pages 364-369

  Chung, Christine H ^a,b   Bagheri, Ashley ^a   D'Souza, Gypsyamber ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Human papillomavirus; Incidence; Natural history; Oral infection; Oropharynx cancer; Prevalence

Indexed keywords

HUMAN; MOUTH DISEASES; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTOR; TRANSMISSION; VIROLOGY;

HUMANS; MOUTH DISEASES; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS;

EID: 84898783282     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.09.003     Document Type: Article

References (64)

1. J.E. Tota, M. Chevarie-Davis, L.A. Richardson, M. Devries, and E.L. Franco Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies Prev Med 53 Suppl 1 2011 S12 S21
2. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
3. M.L. Gillison, W.M. Koch, and R.B. Capone et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
4. G. D'Souza, A.R. Kreimer, and R. Viscidi et al. Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956
5. V. Bouvard, R. Baan, and K. Straif et al. A review of human carcinogens - Part B: biological agents Lancet Oncol 10 2009 321 322
6. N. Munoz, F.X. Bosch, and S. de Sanjose et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527
7. M. Schiffman, G. Clifford, and F.M. Buonaguro Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline Infect Agent Cancer 4 2009 8
8. L. Gissmann, and H. Zur Hausen Partial characterization of viral DNA from human genital warts (Condylomata acuminata) Int J Cancer 25 1980 605 609
9. C.J. Lacey, C.M. Lowndes, and K.V. Shah Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease Vaccine 24 Suppl 3 2006 S3/35-41
10. J.M. Partridge, and L.A. Koutsky Genital human papillomavirus infection in men Lancet Infect Dis 6 2006 21 31
11. L. Gissmann, V. Diehl, H.J. Schultz-Coulon, and H. Zur Hausen Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma J Virol 44 1982 393 400
12. T. Major, K. Szarka, I. Sziklai, L. Gergely, and J. Czegledy The characteristics of human papillomavirus DNA in head and neck cancers and papillomas J Clin Pathol 58 2005 51 55
13. H. zur Hausen Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J Nat Cancer Inst 92 2000 690 698
14. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350
15. C.H. Chung, and M.L. Gillison Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications Clin Cancer Res 15 2009 6758 6762
16. J.D. Howard, and C.H. Chung Biology of human papillomavirus-related oropharyngeal cancer Semin Radiat Oncol 22 2012 187 193
17. T. Crook, J.A. Tidy, and K.H. Vousden Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation Cell 67 1991 547 556
18. R.J. Slebos, M.H. Lee, and B.S. Plunkett et al. P53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein Proc Natl Acad Sci USA 91 1994 5320 5324
19. K. Munger, M. Scheffner, J.M. Huibregtse, and P.M. Howley Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products Cancer Surv 12 1992 197 217
20. A.J. Klingelhutz, and A. Roman Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses Virology 424 2012 77 98
21. J. Doorbar, W. Quint, and L. Banks et al. The biology and life-cycle of human papillomaviruses Vaccine 30 Suppl 5 2012 F55 F70
22. C.B. Woodman, S.I. Collins, and L.S. Young The natural history of cervical HPV infection: unresolved issues Nat Rev Cancer 7 2007 11 22
23. S.I. Pai, and W.H. Westra Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment Annu Rev Pathol 4 2009 49 70
24. G. D'Souza, C. Fakhry, and E.A. Sugar et al. Six-month natural history of oral versus cervical human papillomavirus infection Int J Cancer 121 2007 143 150
25. M.L. Gillison, T. Broutian, and R.K. Pickard et al. Prevalence of oral HPV infection in the United States, 2009-2010 JAMA 307 2012 693 703
26. S. Hariri, E.R. Unger, and M. Sternberg et al. Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006 J Infect Dis 204 2011 566 573
27. C. Fakhry, G. D'Souza, and E. Sugar et al. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women J Clin Microbiol 44 2006 4479 4485
28. E.F. Dunne, E.R. Unger, and M. Sternberg et al. Prevalence of HPV infection among females in the United States JAMA 297 2007 813 819
29. A.R. Kreimer, A. Villa, and A.G. Nyitray et al. The epidemiology of oral HPV infection among a multinational sample of healthy men Cancer Epidemiol Biomarkers Prev 20 2011 172 182
30. R.K. Pickard, W. Xiao, T.R. Broutian, X. He, and M.L. Gillison The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years Sex Transm Dis 39 2012 559 566
31. Z.R. Edelstein, S.M. Schwartz, and S. Hawes et al. Rates and determinants of oral human papillomavirus infection in young men Sex Transm Dis 39 2012 860 867
32. G. D'Souza, Y. Agrawal, J. Halpern, S. Bodison, and M.L. Gillison Oral sexual behaviors associated with prevalent oral human papillomavirus infection J Infect Dis 199 2009 1263 1269
33. E.M. Smith, S. Swarnavel, and J.M. Ritchie et al. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents Pediatr Infect Dis J 26 2007 836 840
34. K.F. Summersgill, E.M. Smith, and B.T. Levy et al. Human papillomavirus in the oral cavities of children and adolescents Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 2001 62 69
35. A.R. Kreimer, R.K. Bhatia, and A.L. Messeguer et al. Oral human papillomavirus in healthy individuals: a systematic review of the literature Sex Transm Dis 37 2010 386 391
36. Beachler DC, D'Souza G, Sugar EA, et al. Differences in oral and anal HPV natural history among HIV-infected individuals. In: Proceedings of the 28th international papillomavirus conference; 2012. p. 213.
37. H.M. Koskimaa, T. Waterboer, and M. Pawlita et al. Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes J Pediatr 160 2011 837 843
38. R. Haddad, C. Crum, and Z. Chen et al. HPV16 transmission between a couple with HPV-related head and neck cancer Oral Oncol 44 2008 812 815
39. K. Hemminki, C. Dong, and M. Frisch Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands Eur J Cancer Prev 9 2000 433 437
40. N. Termine, L. Giovannelli, and D. Matranga et al. Oral human papillomavirus infection in women with cervical HPV infection: new data from an Italian cohort and a metanalysis of the literature Oral Oncol 47 2011 244 250
41. S.G. Parisi, M. Cruciani, and R. Scaggiante et al. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men BMC Infect Dis 11 2011 150
42. J.M. Palefsky, E.A. Holly, M.L. Ralston, M. Da Costa, and R.M. Greenblatt Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women J Infect Dis 183 2001 383 391
43. M. Rintala, S. Grenman, M. Puranen, and S. Syrjanen Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV family study J Clin Virol 35 2006 89 94
44. A.R. Kreimer, A.J. Alberg, and R. Daniel et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus J Infect Dis 189 2004 686 698
45. S. Videla, L. Darwich, and M.P. Canadas et al. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men Sex Transm Dis 40 2013 3 10
46. A. Kreimer Pierce Campbell C, Lin H, et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort Lancet 382 9895 2013 877 887
47. A.B. Moscicki, J.H. Ellenberg, S. Farhat, and J. Xu Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type J Infect Dis 190 2004 37 45
48. D.C. Beachler, K.M. Weber, and J.B. Margolick et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults Cancer Epidemiol Biomarkers Prev 21 2012 122 133
49. M. Zhao, E. Rosenbaum, and A.L. Carvalho et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer Int J Cancer 117 2005 605 610
50. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
51. M.L. Gillison, G. D'Souza, and W. Westra et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers J Natl Cancer Inst 100 2008 407 420
52. R. Halpert, R.G. Fruchter, and A. Sedlis et al. Human papillomavirus and lower genital neoplasia in renal transplant patients Obstet Gynecol 68 1986 251 258
53. M. Frisch, R.J. Biggar, and J.J. Goedert Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome J Natl Cancer Inst 92 2000 1500 1510
54. E.M. Smith, L.M. Rubenstein, T.H. Haugen, E. Hamsikova, and L.P. Turek Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers Cancer Causes Control 21 2010 1369 1378
55. K.M. Applebaum, C.S. Furniss, and A. Zeka et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer J Natl Cancer Inst 99 2007 1801 1810
56. M.L. Gillison, Q. Zhang, and R. Jordan et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer J Clin Oncol 30 2012 2102 2111
57. A. Nasman, P. Attner, and L. Hammarstedt et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125 2009 362 366
58. S. Syrjanen HPV infections and tonsillar carcinoma J Clin Pathol 57 2004 449 455
59. A. Auluck, G. Hislop, and C. Bajdik et al. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience Cancer 116 2010 2635 2644
60. M. Blomberg, A. Nielsen, C. Munk, and S.K. Kjaer Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites Int J Cancer 129 2011 733 741
61. L. Hammarstedt, D. Lindquist, and H. Dahlstrand et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer Int J Cancer 119 2006 2620 2623
62. J. Koshiol, L. Lindsay, and J.M. Pimenta et al. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis Am J Epidemiol 168 2008 123 137
63. < http://www.nccn.org >; 2013.
64. R. Herrero, W. Quint, and A. Hildesheim et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination PLOS ONE 8 7 2013 e68329